BUSINESS ImmunityBio Presents Favorable Comparative Effectiveness Data in Complete Response Rates of NAI + BCG Versus Nadofaragene and TAR-200 at AUA 2026 Tuesday, May 19, 2026 · immunitybio contacts: Advertisement Read Original Article → Related Dispatches [US] · Jun 4 U.S. House committee rejects Moore’s funding proposal for drinking water in Southern West Virginia [US] · Jun 4 NuScale Power Stock Is Down 20%. Is It Finally Time to Buy? [US] · May 30 The Chip That Lifted a Nation – and What It Means for Your Portfolio